New treatments to improve memory in Alzheimer's disease
Development of Novel Small molecule modulators of synaptic plasticity for the treatment of AD-induced cognitive decline
This study is testing a new medication called JB2 to see if it can help improve memory and learning by boosting brain health in people with early Alzheimer's disease.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Encue INC. NIH-funded |
| Lab location | 1 site (Evanston, United States) |
| Project ID | NIH-11007127 on NIH RePORTER |
What this research studies
This research focuses on developing a new small molecule, JB2, that aims to enhance synaptic plasticity, which is crucial for learning and memory. By targeting the insulin-like growth factor 2 receptor (IGF2R), JB2 seeks to restore synaptic health in the early stages of Alzheimer's disease (AD). The approach involves understanding how JB2 can activate specific receptors in the brain to improve cognitive function and potentially slow down the progression of AD. Patients may be monitored for changes in memory and cognitive abilities as part of the research.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with early-stage Alzheimer's disease who are experiencing cognitive decline.
Not a fit: Patients with advanced Alzheimer's disease or those with other forms of dementia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly improve memory and cognitive function in patients with Alzheimer's disease.
How similar studies have performed: Previous research has shown promise in enhancing synaptic plasticity as a therapeutic target for Alzheimer's disease, suggesting potential for success with this novel approach.
Where this research is happening
Evanston, United States
- Encue INC. — Evanston, United States (Active)
Researchers
- Principal investigator: Loffler, Alicia — Encue INC.
- Study coordinator: Loffler, Alicia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.